CLINICAL_TRIALS
research
· 2026-03-06
Clinical Trial Update: Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma [Phase 1]
Summary
A Phase 1 clinical trial evaluating the safety and potential usefulness of liposomal curcumin in patients with refractory or relapsed multiple myeloma. The stud…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma Refractory, Multiple Myeloma in Relapse | Phase 1 | Status: NOT_YET_RECRUITING